Type 2 diabetes represents a significant public health problem, due to its alarming
prevalence and associated complications such as cardiovascular disease (CVD), heart
failure (HF), and chronic kidney disease (CKD). These are closely interconnected and
constitute the main causes of morbidity and mortality in people with type 2 diabetes.
[1]
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Diabetes Research and Clinical PracticeAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Therapy. 2022; 13: 1-3
Diabetes Obes Metab. 2020 Sep; 22(9): 1607–1618.
Diabetes Ther. 2022 Feb; 13(2): 275–286.
Diabetes Obes Metab 2022 Jul;24(7): 1277-1287.doi: 10.1111 / dom.14698.
WHO Europe. Registries and information systems for diabetes care in the WHO European Region: preliminary findings for consultation.
https://www.idf.org/our-activities/epidemiology-research/t2d-and-cardio-renal-complications
Article info
Publication history
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2023 Published by Elsevier B.V.
